Sofinnova Investments, Inc. Reata Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

$1.06 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $24.2 Million - $32.2 Million	-305,212 Reduced 48.63%	322,471 $32.9 Million
Q1 2023 May 11, 2023	SELL	$30.85 - $93.17 $11.2 Million - $33.9 Million	-364,346 Reduced 36.73%	627,683 $57.1 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $3.85 Million - $7.31 Million	173,653 Added 21.22%	992,029 $37.7 Million
Q3 2022 Nov 08, 2022	BUY	$19.41 - $36.49 $670,130 - $1.26 Million	34,525 Added 4.4%	818,376 $20.6 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $3.75 Million - $6.62 Million	181,306 Added 30.09%	783,851 $23.8 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $14.5 Million - $23.9 Million	602,545 New	602,545 $19.7 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $4.03 Million - $17.5 Million	-157,488 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $7.79 Million - $11.1 Million	77,887 Added 97.85%	157,488 $15.8 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $12.4 Million - $24 Million	-158,919 Reduced 66.63%	79,601 $11.3 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $8.44 Million - $11.9 Million	89,583 Added 60.15%	238,520 $23.8 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $8.2 Million - $14.8 Million	80,322 Added 117.06%	148,937 $18.4 Million
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $5.2 Million - $9.08 Million	55,580 Added 426.39%	68,615 $6.69 Million
Q2 2020 Aug 13, 2020	BUY	$126.3 - $176.56 $1.65 Million - $2.3 Million	13,035 New	13,035 $2.03 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $11.1 Million - $32.4 Million	-148,669 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $2.36 Million - $3.17 Million	33,133 Added 28.68%	148,669 $11.9 Million
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $3.93 Million - $4.77 Million	50,505 Added 77.66%	115,536 $10.9 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $4.82 Million - $9.46 Million	-92,953 Reduced 58.84%	65,031 $5.56 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $7.7 Million - $12.1 Million	157,984 New	157,984 $8.86 Million
Q3 2018 Nov 15, 2018	SELL	$35.64 - $92.06 $3.2 Million - $8.28 Million	-89,909 Closed	0 $0
Q2 2018 Nov 15, 2018	BUY	$19.94 - $40.96 $1.61 Million - $3.3 Million	80,602 Added 866.04%	89,909 $3.14 Million
Q2 2018 Aug 14, 2018	SELL	$19.94 - $40.96 $400,315 - $822,312	-20,076 Reduced 68.33%	9,307 $325,000
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $587,660 - $887,072	29,383 New	29,383 $603,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account